Authors: TOURANI JM JAILLONABRAHAM C LUCAS V CHRETIEN Y MAYEUR D DIPALMA M BOAZIZ C GRISE P VARETTE C PAVLOVITCH JM LARREGAIN D ECSTEIN E UNTEREINER M ANDRIEU JM

Citation: Jm. Tourani et al., SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 IN TREATMENT OF PATIENTSWITH METASTATIC RENAL-CELL CARCINOMA - 3-YEAR RESULTS OF SCAPP-I TRIAL, Bulletin du cancer, 84(4), 1997, pp. 351-356

Authors: TOURANI JM GRISE P LUCAS V MAYEUR D DUFOUR B DIPALMA M BOAZIZ C PAVLOVITCH JM PUJADELAURAINE E LARREGAIN D UNTEREINER M

Citation: Jm. Tourani et al., INTERLEUKIN-2 IN OUTPATIENTS WITH RENAL-CELL CARCINOMA - SCAPP1 TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 297-300

Authors: TOURANI JM LUCAS V MAYEUR D DUFOUR B DIPALMA M BOAZIZ C GRISE P VARETTE C PAVLOVITCH JM PUJADELAURAINE E LARREGAIN D ECSTEIN E UNTEREINER M VUILLEMIN E MERRAN S ANDRIEU JM

Citation: Jm. Tourani et al., SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 (RIL-2) IN OUT-PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA - RESULTS OF A MULTICENTER SCAPP1 TRIAL, Annals of oncology, 7(5), 1996, pp. 525-528